Noul Co., Ltd. Logo

Noul Co., Ltd.

AI-powered, automated point-of-care diagnostics for accessible global healthcare.

376930 | KO

Overview

Corporate Details

ISIN(s):
KR7376930004
LEI:
Country:
South Korea
Address:
경기도 용인시 수지구 광교중앙로 338, 비동 10층, 용인시
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Noul Co., Ltd. is a biotechnology company that develops decentralized, AI-powered diagnostic solutions. Its flagship product, the miLab™ platform, is an all-in-one, fully automated point-of-care (POC) testing device for in-vitro diagnosis. The platform streamlines the entire diagnostic workflow by integrating sample staining, digital imaging, and embedded AI analysis for blood and tissue samples. Established in 2015, Noul aims to improve global access to essential diagnostics, with applications in cancer and infectious disease detection, particularly for resource-limited healthcare environments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Management Reports
기업가치제고계획(자율공시) (2025년 상반기 이행현황)
Korean 8.6 KB
2025-09-01 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-25 00:00
Regulatory Filings
투자판단관련주요경영사항 (마이랩(miLab)플랫폼 등 총 5종 제품 가나 공급 및 독점 판매권 부여 계약 체결)
Korean 7.9 KB
2025-08-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-12 00:00
Earnings Release
[기재정정]연결재무제표기준영업(잠정)실적(공정공시)
Korean 25.7 KB
2025-08-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.7 KB
2025-08-12 00:00
Remuneration Information
[기재정정]주식매수선택권부여에관한신고
Korean 24.3 KB
2025-08-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.8 KB
2025-08-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 23.4 KB
2025-07-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-02 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.1 KB
2025-06-30 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-06-20 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 15.6 KB
2025-06-20 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 7.2 KB

Automate Your Workflow. Get a real-time feed of all Noul Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Noul Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Noul Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Safe S.A. Logo
Appears to operate in the orthopedics sector; specific details are unavailable.
France
ALSAF
Sanara MedTech Inc. Logo
Develops med-tech for surgical, wound, and skin care, plus telehealth for providers.
United States of America
SMTI
SANYU CO.,LTD. Logo
A manufacturer of medical analytical equipment focused on R&D for next-generation systems.
Japan
5697
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden
CMOTEC
Scandinavian Real Heart AB Logo
Develops a total artificial heart that mimics natural heart function for heart failure patients.
Sweden
HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany
1SXP
SD BIOSENSOR  INC. Logo
South Korea
137310
SeaStar Medical Holding Corp Logo
Develops a device-based therapy for hyperinflammation in critically ill ICU patients.
United States of America
ICU
SEJONG MEDICAL Co.Ltd., Logo
South Korea
258830
Senseonics Holdings, Inc. Logo
Develops the first long-term, implantable glucose sensor for diabetes management.
United States of America
SENS

Talk to a Data Expert

Have a question? We'll get back to you promptly.